Correction: Isolation of phages for phage therapy: a comparison of spot tests and efficiency of plating analyses for determination of host range and efficacy.

In Table 3, the ESBL, SARA, SARB should be under separated headline. Please see the corrected Table 3 here.

Table 3

Results of spot test assays and efficiency of plating (EOP) on ESBL-E. coli, SARA, and SARB strains.

Bacteriophage	SU10	SU16	SU27	SU32	SU57	SU63	Average	%
Number of ESBL strains (n = 20)
Lysed strains in spot test assays	7	9	13	7	2	9	7.83	39
High production, (EOP ≥ 0.5)	2	5	4	1	1	1	2.33	12
Medium production, (0.1≤ EOP <0.5)	0	0	0	0	0	0	0.00	0
Low production, (0.001< EOP <0.1)	2	0	1	0	0	0	0.50	3
No production, (EOP ≤ 0.001)	3	4	8	6	1	8	5.00	25
Number of SARA strains (n = 72)
Lysed strains in spot test assays	2	1	2	7	3	1	2.67	4
High production, (EOP ≥ 0.5)	0	0	0	0	0	0	0.00	0
Medium production, (0.1≤ EOP <0.5)	0	0	0	2	1	0	0.50	1
Low production, (0.001< EOP <0.1)	0	0	0	0	0	0	0.00	0
No production, (EOP ≤ 0.001)	2	1	2	5	2	1	2.17	3
Number of SARB strains (n = 70)
Lysed strains in spot test assays	3	2	1	5	4	4	3.17	16
High production, (EOP ≥ 0.5)	0	0	0	0	1	0	0.17	1
Medium production, (0.1≤ EOP <0.5)	0	0	0	1	0	0	0.17	1
Low production, (0.001< EOP <0.1)	0	0	0	1	0	0	0.17	1
No production, (EOP ≤ 0.001)	3	2	1	3	3	4	2.67	13
High EOP /spot test ratio	0.17	0.42	0.25	0.05	0.22	0.07	0.20	-
High+Medium/spot test ratio	0.17	0.42	0.25	0.21	0.33	0.07	0.24	-
Sum of EOP values	1.94	5.85	3.96	2.67	3.30	1.30	3.17	-